Pharma IQ Glossary: Biomarker
A Biomarker is defined as anything that can be used as an indicator of a particular disease state or some other biological state of an organism. A biomarker can be a substance that is introduced into an organism as a means to examine organ function or other aspects of health. For example, rubidium chloride is used as a radioactive isotope to evaluate perfusion of heart muscle. It can also be a substance whose detection indicates a particular disease state, for example, the presence of an antibody may indicate an infection. Biomarkers can be specific cells, molecules, or genes, gene products, enzymes, or hormones.
Biomarkers: What is new?
August 14 by Joyce El HokayemHuman genetic research scientist, Dr Joyce El Hokayem, provides a concise overview of the emergence and future for biomarkers.
The Road To ‘Personalised Medicine’ with AstraZeneca's Duncan McHale
August 17 by Pharmaceuticals & Biotechnology EditorDuncan McHale, Vice-President for Personalised Healthcare and Biomarkers, Astrazeneca, joins Helen Winsor of Pharma IQ. In this interview he discusses the importance of biomarker discov...
Improving Biomarker Development Work Flow in Phase I Clinical Development
September 07 by Helen WinsorReto Ossola, Group Leader for Biomarker Research at Biognosys, joins Pharma IQ to discuss the main challenges in biomarker development and some key ways to address these. Ossola offers some best...
Streamlining the Development and Validation Process in Discovery to Phase I Clinical Development
September 05 by Pharma IQReto Ossola, Group Leader for Biomarket Research at Biognosys, joins Helen Winsor from Pharma IQ, to discuss phase I clinical development. He outlines where he sees the main challenges in biomarker de...
